Oshima A, Hirata N, Ubukata T, Umeda K, Fujimoto I
Int J Cancer. 1986 Dec 15;38(6):829-33. doi: 10.1002/ijc.2910380608.
In order to evaluate the effectiveness of a mass screening program for stomach cancer, a case-control study was conducted in Nose town in Osaka, Japan. The case series consisted of all deaths from stomach cancer during the period 1969-1981 (54 in males and 37 in females). For each case, 3 controls of the same sex and from the same precinct as the case, and born within 5 years of the case birth-year, were selected at random from Nose town residents alive at the date of death of the relevant case. We then investigated whether each case and corresponding controls had ever had screening tests before the date of diagnosis of the case. From the matched analysis of the distribution of screening in case-control combination, the odds ratio of screened vs. unscreened among those who died from stomach cancer compared to those who did not was calculated as 0.595 (90% confidence interval: 0.338-1.045) among males and 0.382 (0.185-0.785) among females. When the screening tests conducted within 12 months of diagnosis were ignored on the presumption that they were symptom-related, the odds ratio was calculated as 0.519 (0.297-0.905) among males and 0.486 (0.239-0.986) among females. These data strongly suggest that the mass screening program is effective in reducing stomach cancer mortality.
为评估胃癌大规模筛查项目的效果,在日本大阪的能势町开展了一项病例对照研究。病例组包括1969年至1981年期间所有因胃癌死亡的病例(男性54例,女性37例)。对于每一例病例,从能势町在相关病例死亡日期仍在世的居民中,随机选取3名与病例同性、来自同一辖区且出生年份与病例相差不超过5年的对照。然后,我们调查了每例病例及其相应对照在病例诊断日期之前是否曾接受过筛查检测。通过对病例对照组合中筛查分布的匹配分析,计算出胃癌死亡者中接受筛查者与未接受筛查者相比的比值比,男性为0.595(90%置信区间:0.338 - 1.045),女性为0.382(0.185 - 0.785)。如果假定在诊断前12个月内进行的筛查检测与症状相关而将其忽略,男性的比值比计算为0.519(0.297 - 0.905),女性为0.486(0.239 - 0.986)。这些数据有力地表明,大规模筛查项目在降低胃癌死亡率方面是有效的。